tiprankstipranks
Advertisement
Advertisement

AU:OCC Stock Latest News

Orthocell to Showcase Regenerative Growth Strategy at Canaccord Conference
Company AnnouncementsOrthocell to Showcase Regenerative Growth Strategy at Canaccord Conference
7h ago
OCC
Orthocell Targets Global Investors at Canaccord Growth Conference
PremiumCompany Announcements
Orthocell Targets Global Investors at Canaccord Growth Conference
1d ago
OCC
Orthocell Relocates Registered Office to Murdoch University Campus
PremiumCompany Announcements
Orthocell Relocates Registered Office to Murdoch University Campus
9d ago
OCC
Orthocell Issues Cautious Q4 FY26 Investor Presentation Disclaimer
PremiumCompany Announcements
Orthocell Issues Cautious Q4 FY26 Investor Presentation Disclaimer
29d ago
OCC
Orthocell hits record revenue as Remplir adoption accelerates and global rollout advances
PremiumCompany Announcements
Orthocell hits record revenue as Remplir adoption accelerates and global rollout advances
1M ago
OCC
Orthocell to Unveil Quarterly Results and Detail U.S. Rollout of Remplir
PremiumCompany AnnouncementsOrthocell to Unveil Quarterly Results and Detail U.S. Rollout of Remplir
1M ago
OCC
Orthocell Expands Humanitarian Use of Remplir Nerve Repair Device in Ukraine
Premium
Company Announcements
Orthocell Expands Humanitarian Use of Remplir Nerve Repair Device in Ukraine
1M ago
OCC
Orthocell issues new shares after employee option exercise under equity incentive plan
Premium
Company Announcements
Orthocell issues new shares after employee option exercise under equity incentive plan
3M ago
OCC
Orthocell Seeks ASX Quotation for 445,696 New Shares
PremiumCompany Announcements
Orthocell Seeks ASX Quotation for 445,696 New Shares
3M ago
OCC
Orthocell logs first Remplir sales in Canada, advancing global nerve repair rollout
PremiumCompany Announcements
Orthocell logs first Remplir sales in Canada, advancing global nerve repair rollout
3M ago
OCC
Orthocell’s Remplir Nerve Repair Device Posts Near-90% Success in Real-World Study
PremiumCompany Announcements
Orthocell’s Remplir Nerve Repair Device Posts Near-90% Success in Real-World Study
4M ago
OCC
Orthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
PremiumCompany Announcements
Orthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
4M ago
OCC
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
PremiumCompany AnnouncementsOrthocell records first U.S. military hospital case for Remplir after DoD–VA approval
4M ago
OCC
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
Premium
Company Announcements
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
4M ago
OCC
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
Premium
Company Announcements
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
4M ago
OCC
Orthocell to Outline March-Quarter Results and Remplir Rollout in Investor Webinar
PremiumCompany Announcements
Orthocell to Outline March-Quarter Results and Remplir Rollout in Investor Webinar
4M ago
OCC
Orthocell courts investors with biotech presentation as global product rollout advances
PremiumCompany Announcements
Orthocell courts investors with biotech presentation as global product rollout advances
4M ago
OCC
Orthocell reports lapse of 16,567 retention rights, trimming potential equity
PremiumCompany Announcements
Orthocell reports lapse of 16,567 retention rights, trimming potential equity
5M ago
OCC
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
PremiumCompany Announcements
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
5M ago
OCC
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
PremiumCompany AnnouncementsOrthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
5M ago
OCC
Orthocell director Michael McNulty increases on‑market shareholding
Premium
Company Announcements
Orthocell director Michael McNulty increases on‑market shareholding
6M ago
OCC
Orthocell Director Increases Shareholding Through On-Market Purchase
Premium
Company Announcements
Orthocell Director Increases Shareholding Through On-Market Purchase
6M ago
OCC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >